Andy Lee of Vincere Biosciences. "Our innovative pipeline consists of small molecules designed to boost mitophagy, with the potential to become the first-ever medicines capable of slowing or stopping Parkinson's disease and other age-related conditions."Over 321 books from 170 plus interviews over 5 yearshttps://www.learningwithlowell.com/over-321-books-from-170-interviews-over-5-years-for-autodidacts/Newsletter sign up (new and exciting developments)https://learningwithlowell.us12.list-manage.com/subscribe?u=08ed8a56013d8b3a3c01e27fc&id=6ecaa9189bhttps://youtu.be/M-XXi1FLnXwPODCAST INFO:The Learning With Lowell show is a series for the everyday mammal. In this show we’ll learn about leadership, science, and people building their change into the world. The goal is to dig deeply into people who most of us wouldn’t normally ever get to hear. The Host of the show – Lowell Thompson- is a lifelong autodidact, serial problem solver, and founder of startups.LINKSSpotify: https://open.spotify.com/show/66eFLHQclKe5p3bMXsCTRHRSS: https://www.learningwithlowell.com/feed/podcast/Youtube: https://www.youtube.com/channel/UCzri06unR-lMXbl6sqWP_-QYoutube clips: https://www.youtube.com/channel/UC-B5x371AzTGgK-_q3U_KfAWebsite: https://www.learningwithlowell.com/Andy Lee Linkshttps://vincerebio.com/teamhttps://www.facebook.com/Neuroinitiative/https://twitter.com/VincereBiohttps://twitter.com/andy_d_leeTimestamps